Additional information
Brown Powder powder
1422619-13-3
ACI-180605
(3R,6E)-7-[4-(4-Fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl]- 3-hydroxy-5-oxohept-6-enoic Acid
3-Hydroxy-5-keto Rosuvastatin
C22H26FN3O6S
479.52
Ambient
2-8°C
5-Oxo Rosuvastatin
HMG-CoA reductase inhibitor





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)